ARCHAEA-ExPRESs targeting of alpha-tubulin 4 mRNA: a model for high-specificity trans-splicing
- PMID: 20371619
- DOI: 10.1096/fj.10-154658
ARCHAEA-ExPRESs targeting of alpha-tubulin 4 mRNA: a model for high-specificity trans-splicing
Abstract
Effectiveness of trans-splicing-mediated mRNA reprogramming depends on specificity and efficiency. We have previously developed a new strategy (ARCHAEA-ExPRESs) that uses a tRNA endonuclease derived from Archaea and its natural substrate, the bulge-helix-bulge (BHB) structure. ARCHAEA-ExPRESs provides increased specificity in functional targeting. In fact, this system is based on a double check, the base pairing and the formation of a BHB structure between the target mRNA and the targeting RNA. In this study, we demonstrate the high specificity of ARCHAEA-ExPRESs by tagging the endogenous alpha-tubulin 4 via trans-splicing. Alpha-tubulin 4 belongs to a gene family sharing high degree of nucleotide sequence homology. The formation of a perfect BHB structure between targeting RNAs and the isotype alpha-tubulin 4 enables selective trans-splicing. Most important, ARCHAEA-ExPRESs functionality is conserved in vivo following transient expression of archaeal tRNA endonuclease in mouse liver. Production of the recombinant protein is strictly dependent on the expression of the archaeal endonuclease, and the efficiency of the system depends on the relative amount of the target and targeting mRNAs. These data prove the effectiveness of ARCHAEA-ExPRESs in an endogenous highly demanding context and disclose the possibility to utilize this system in a variety of technological or therapeutic applications.
Similar articles
-
An archaeal endoribonuclease catalyzes cis- and trans- nonspliceosomal splicing in mouse cells.Nat Biotechnol. 2003 Dec;21(12):1499-504. doi: 10.1038/nbt908. Epub 2003 Nov 2. Nat Biotechnol. 2003. PMID: 14595336
-
Highly efficient, in vivo optimized, archaeal endonuclease for controlled RNA splicing in mammalian cells.FASEB J. 2013 Sep;27(9):3466-77. doi: 10.1096/fj.13-231993. Epub 2013 May 16. FASEB J. 2013. PMID: 23682120
-
A generalizable strategy for imaging pre-mRNA levels in living subjects using spliceosome-mediated RNA trans-splicing.J Nucl Med. 2008 Jul;49(7):1146-54. doi: 10.2967/jnumed.107.047662. Epub 2008 Jun 13. J Nucl Med. 2008. PMID: 18552150
-
Gene therapy progress and prospects: reprograming gene expression by trans-splicing.Gene Ther. 2005 Oct;12(20):1477-85. doi: 10.1038/sj.gt.3302596. Gene Ther. 2005. PMID: 16121205 Review.
-
Spliceosome-mediated RNA trans-splicing.Mol Ther. 2005 Dec;12(6):1006-12. doi: 10.1016/j.ymthe.2005.09.006. Epub 2005 Oct 12. Mol Ther. 2005. PMID: 16226059 Review.
Cited by
-
Archaeal tRNA-Splicing Endonuclease as an Effector for RNA Recombination and Novel Trans-Splicing Pathways in Eukaryotes.J Fungi (Basel). 2021 Dec 12;7(12):1069. doi: 10.3390/jof7121069. J Fungi (Basel). 2021. PMID: 34947051 Free PMC article.
-
Efficient system for upstream mRNA trans-splicing to generate covalent, head-to-tail, protein multimers.Sci Rep. 2019 Feb 19;9(1):2274. doi: 10.1038/s41598-018-36684-7. Sci Rep. 2019. PMID: 30783185 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources